MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income

Holdings History for MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Symbol: MYGN on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2019		-0.86%	$0	0	-167,610	-100%	$4.53	Q2 2019
31 Mar 2019	0.86%	-0.72%	$5,565,000	167,610	-139,935	-46%	$33.20	Q1 2019
31 Dec 2018	1.2%	-0.24%	$8,940,000	307,545	-61,810	-17%	$29.07	Q4 2018
30 Sep 2018	1.5%	-0.13%	$16,990,000	369,355	-30,070	-7.5%	$46.00	Q3 2018
30 Jun 2018	1.4%	+1.4%	$14,926,000	399,425	+399,425	NEW	$37.37	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.